Peptide sequencing is the process of determining the order of amino acids in a peptide. Scientists use this information to identify an unknown peptide, check whether a synthetic compound matches its intended sequence, or investigate changes in a research sample.
The order matters. Two peptides can contain the same amino acids but arrange them differently. They may have the same total molecular mass while differing in their structure and interactions.
To determine that order, laboratories commonly use tandem mass spectrometry or Edman degradation. These methods examine peptides in different ways, producing evidence that researchers interpret as an amino acid sequence.
What Does a Peptide Sequence Tell Scientists?
A peptide consists of amino acid residues connected by peptide bonds. Its sequence describes the order of those residues, usually written from the amino end, called the N-terminus, to the carboxyl end, called the C-terminus.
For example, a short sequence might be written as:
Ala–Gly–Ser–Lys
Using one-letter amino acid codes, the same sequence becomes:
AGSK
This tells researchers which amino acids are present and where each sits in the chain.
However, a sequence string does not necessarily describe the entire molecule. Terminal modifications, disulfide connections, and other chemical features may require additional notation and testing.
For a research sample, it helps to separate three questions:
- Composition: Which amino acids are present?
- Sequence: In what order are they connected?
- Chemical structure: What modifications or additional connections are present?
A complete analytical assessment may need evidence for all three.
How Does Peptide Sequencing Work?
Peptide sequencing methods generate information that reveals amino acid order. Mass spectrometry measures charged peptide fragments. Edman degradation removes and identifies residues sequentially from an accessible N-terminus.
The appropriate method depends on the sample and the question being asked. Confirming a known synthetic sequence is a different task from reconstructing a completely unknown peptide.
Peptide Sequencing by Mass Spectrometry
In peptide sequencing by mass spectrometry, researchers use the masses of peptide fragments to investigate sequence.
A common workflow combines liquid chromatography with tandem mass spectrometry, abbreviated LC-MS/MS. Liquid chromatography separates sample components before mass analysis.
When studying proteins, scientists often digest them into smaller peptides first. For an isolated short peptide, digestion may be unnecessary. Thermo Fisher describes peptide-level LC-MS analysis as a central approach for identifying proteins and investigating their modifications. Thermo Fisher Scientific – AU
The basic workflow has five stages:
- Prepare the sample. Remove or reduce substances that interfere with analysis.
- Separate the components. Use chromatography when needed to reduce sample complexity.
- Measure precursor ions. Detect intact, charged peptide molecules.
- Fragment selected ions. Break selected peptide ions into smaller charged pieces.
- Interpret the spectrum. Compare the fragments with candidate sequences or reconstruct a sequence from the data.
The instrument measures mass-to-charge ratio, written as m/z. Charge must therefore be considered when interpreting a spectrum.
How Do Fragment Ions Reveal Amino Acid Order?
Different fragmentation methods produce different fragment-ion patterns. Two important families are b ions and y ions.
- b ions retain the N-terminal portion of the peptide.
- y ions retain the C-terminal portion.
Their labels also indicate how many residues the fragment contains. Researchers look for related fragments that form a sequence ladder.
For neighboring fragments within the same series, mass differences can indicate the additional amino acid residue. This interpretation must account for charge state, modifications, and other possible fragment types. Thermo Fisher’s documentation explains these ion families and how their positions relate to the peptide backbone. topic
A useful way to picture this is to imagine several overlapping pieces of the same sentence. Each piece contains part of the message. Together, they help establish the original order.
Real spectra are less tidy. Some fragments are missing, and other signals may overlap. A credible sequence assignment depends on the overall pattern, not one matching peak.
What Is De Novo Peptide Sequencing?
De novo peptide sequencing reconstructs an amino acid sequence from fragmentation data without requiring an exact sequence match in a reference database.
It is particularly useful when researchers investigate an unknown peptide or a sequence that may not be represented in available databases.
Database searching and de novo sequencing answer the problem differently:
| Approach | Main question |
|---|---|
| Database searching | Which listed sequence best explains this spectrum? |
| De novo sequencing | What sequence can be inferred directly from these fragments? |
| Known-sequence verification | Does the experimental evidence support the expected sequence? |
De novo analysis can produce a full sequence, a partial sequence, or several possible candidates. Missing fragmentation evidence can leave sections unresolved. The University of California, Irvine’s mass spectrometry facility describes de novo sequencing as determining peptide sequences from tandem mass spectrometry data. ucimsf.ps.uci.edu
Software can help propose sequences, but a proposed answer still needs assessment. Researchers should examine whether the observed fragments support each important part of the assignment.
What Is Edman Degradation?
Edman degradation identifies amino acids one at a time from the N-terminus of a peptide or protein.
During each cycle, the terminal residue undergoes a chemical reaction, is released as a derivative, and is identified. Repeating the process reveals successive residues.
This makes Edman sequencing useful when the main question concerns the beginning of a sequence.
Its limitations are important:
- The method requires an accessible, suitably unblocked N-terminus.
- Mixed samples can produce overlapping signals.
- Sequence quality depends on sample purity and quantity.
- Incomplete reactions and background signals accumulate across cycles.
A blocked N-terminus can prevent conventional Edman sequencing from starting. The Medical University of Innsbruck’s protein core facility identifies this as a key sample limitation. i-med.ac.at
There is no single sequence length that every sample can reliably achieve. Instrument documentation notes that read length depends on reaction efficiency and sample characteristics. documents.thermofisher.com
Mass Spectrometry vs. Edman Degradation
Both methods provide sequence information, but they are useful in different situations.
| Feature | Tandem mass spectrometry | Edman degradation |
|---|---|---|
| Basic principle | Measures peptide-fragment ions | Removes terminal residues in successive cycles |
| Main evidence | Fragmentation spectrum | Identified residue from each cycle |
| Common role | Peptide identification, sequence verification, modification analysis | Direct N-terminal sequence analysis |
| Mixed samples | Often analyzed after chromatographic separation | Mixtures can complicate interpretation |
| Important limitation | Missing or ambiguous fragment evidence | Blocked N-termini and declining cycle efficiency |
Choosing between them starts with the analytical goal. A laboratory may need to confirm a peptide’s identity, inspect its N-terminus, or resolve a specific uncertainty. Those tasks do not always require the same workflow.
Is Measuring Molecular Mass Enough to Confirm a Sequence?
No. A matching molecular mass alone does not establish amino acid order.
Consider these two illustrative sequences:
- Ala–Gly–Ser–Lys
- Gly–Ala–Ser–Lys
They contain the same residues in different positions. With equivalent terminal chemistry, their intact molecular masses are the same.
An intact-mass result can support a proposed identity, but it cannot distinguish every alternative structure. Fragmentation evidence provides information about how residues are arranged.
This is why a report showing the expected molecular weight should not automatically be described as complete sequence confirmation.
Is Peptide Sequencing the Same as Purity Testing?
Peptide sequencing and purity testing address different questions.
Sequence analysis asks: Does the evidence support the intended amino acid order?
Purity analysis asks: How much of the measured sample signal belongs to the main component under the selected analytical conditions?
For example, an HPLC chromatogram can show a dominant peak. That result does not, by itself, reveal the complete sequence of the material in that peak.
Likewise, identifying the intended peptide does not automatically establish the absence of every impurity.
When reviewing analytical documentation, distinguish between:
| Result | What it helps assess |
|---|---|
| Chromatographic purity | Separation and relative signals of detected components |
| Intact molecular mass | Agreement with an expected molecular mass |
| MS/MS sequence evidence | Support for residue order and certain modifications |
| Peptide content measurement | Amount of peptide present using the stated method |
These results complement one another. None should be described as answering every quality question.
What Can Make Peptide Sequence Analysis Difficult?
Incomplete Fragmentation
A spectrum may not contain enough informative fragments to support every sequence position. The absence of a useful fragment can leave multiple interpretations.
Leucine and Isoleucine
Leucine and isoleucine have the same molecular mass. Routine mass-based sequence interpretation often cannot distinguish them confidently.
Specialized approaches can provide additional evidence, so this is a method-dependent limitation rather than an absolute impossibility. Research published in Analytical Chemistry describes an approach for distinguishing these residues using high-resolution tandem mass spectrometry. ACS Publications
Chemical Modifications
A modification can alter the mass of a peptide or its fragments. Detecting a mass change and locating that change at a particular residue are separate analytical tasks.
Sample Mixtures
Signals from more than one peptide can complicate interpretation. Sample preparation and separation therefore matter alongside instrument performance.
Unusual Peptide Structures
Cyclic peptides, crosslinked structures, and nonstandard residues may require methods beyond a routine linear-peptide workflow. The analysis should be designed around the actual molecule.
What Should a Peptide Sequencing Report Include?
A useful report should make clear what was measured and how strongly the data support the conclusion.
When requesting or reviewing a report, ask for:
- The sample name and batch identifier.
- The proposed sequence and stated modifications.
- The analytical method used.
- The measured precursor mass or mass-to-charge ratio.
- Supporting fragment assignments or Edman cycle results.
- The confidence criteria used to accept the assignment.
- Any unresolved residues or sequence regions.
- A clear distinction between sequence findings and purity results.
Be specific about sequence coverage. For a protein, this may refer to the portion represented by identified peptides. For a single peptide, a laboratory may instead report fragment coverage or confidence at individual positions. Ask which definition applies.
A report that openly identifies an uncertain position is more informative than one that presents an unsupported complete sequence.
Frequently Asked Questions
What is the difference between peptide sequencing and protein sequencing?
Peptide sequencing examines shorter amino acid chains. Protein sequencing concerns larger chains and may involve breaking a protein into peptides, analyzing them, and interpreting the combined evidence.
Does LC-MS always provide a complete peptide sequence?
No. An LC-MS result may provide retention and intact-mass information without sufficient fragmentation data to establish residue order. Check whether the analysis included MS/MS and what sequence evidence was obtained.
Can scientists sequence an unknown peptide?
Yes. De novo peptide sequencing can infer an unknown sequence from tandem mass spectra. However, the result may be partial or contain uncertain positions.
Can sequencing prove that a sample is pure?
No. Sequence identification and purity assessment are separate measurements. A sample can contain the intended peptide alongside other components.
Why is amino acid order important?
Residue order defines the peptide’s primary structure. Changing that order can change the molecule’s properties even when its amino acid composition and intact mass remain the same.
Peptide sequencing helps researchers connect a sample label with experimental evidence. The strongest interpretation comes from knowing what the method measured, which sequence positions it supports, and where uncertainty remains.
This article is shared on Orion Peptides for scientific education and laboratory research information only. It does not provide guidance for human or veterinary use.
